2017
DOI: 10.1177/0268355517696612
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of incompetent perforators in recurrent venous insufficiency with adhesive embolization and sclerotherapy

Abstract: Recurrent lower limb venous insufficiency is often a challenge in clinical practice and is most commonly due to incompetent perforators. Many of these patients do not have adequate symptom relief with compression and require some form of treatment for incompetent perforator interruption. Various treatment methods have been tried with different efficiencies. Objective To evaluate the feasibility, efficiency and safety of an outpatient combined cyanoacrylate adhesion-sodium tetradecyl sulphate sclerotherapy for … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2017
2017
2025
2025

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 39 publications
0
10
0
Order By: Relevance
“…One concern is the inadequate control of the junction during application of the glue, resulting in glue extension past the sapheno-femoral junction (SFJ)/saphenopopliteal junction (SPJ) into the deep system, as shown in similar CAG-based glue devices. 6 In this scenario, there is a theoretical risk of developing deep vein thrombosis (DVT), along with potentially lifethreatening complications such as pulmonary embolism. As such, current instructions for use (IFU) suggest an arbitrary safety distance to commence glue administration 50 mm caudal to the SFJ for the great saphenous vein (GSV) and SPJ for the small saphenous vein (SSV), respectively, with ultrasound compression 3 cm away from the junction.…”
Section: Introductionmentioning
confidence: 99%
“…One concern is the inadequate control of the junction during application of the glue, resulting in glue extension past the sapheno-femoral junction (SFJ)/saphenopopliteal junction (SPJ) into the deep system, as shown in similar CAG-based glue devices. 6 In this scenario, there is a theoretical risk of developing deep vein thrombosis (DVT), along with potentially lifethreatening complications such as pulmonary embolism. As such, current instructions for use (IFU) suggest an arbitrary safety distance to commence glue administration 50 mm caudal to the SFJ for the great saphenous vein (GSV) and SPJ for the small saphenous vein (SSV), respectively, with ultrasound compression 3 cm away from the junction.…”
Section: Introductionmentioning
confidence: 99%
“…Prasad et al also reported a group of patients with recurrent CVI with a minimum diameter of 3 mm of PVs in the fascial layer. [21] In our study, the average diameter of the PVs of ulcers ≤2 cm was 3.2 ± 1.4 mm, the average diameter of the PVs of ulcers >2 cm was 3.8 ± 1.1 mm, and the comparison between the two groups was statistically significant ( P < .001). Single factor and multiple factor logistic regression analyses were used, confirming that the diameter of PVs around ulcers was an independent risk factor for ulcer diameter.…”
Section: Discussionmentioning
confidence: 50%
“…In a previous study on the usage of undiluted glue for perforator occlusion, the incidence of deep venous extension was 4.8%. 32 Although the method of delivery of cyanoacrylate was different compared to treatment of varicose veins using specialized proprietary cyanoacrylate, the principle is the same, and it could be expected that the results be comparable. Different studies on proprietary cyanoacrylate glue occlusion of saphenous veins have shown different occlusion rates as presented in Table 4.…”
Section: Discussionmentioning
confidence: 99%